jeudi 11 février 2016

Onco Actu du 11 février 2016


1. Biologie

How cancer stem cells dodge the immune system [Scope Blog]

3.1 Tabac

More than 8 percent of women smoke while pregnant, despite risks [STAT]

3.5 Prévention - UV

New NICE guidelines on sun exposure warn 'tanning is unsafe' [NHS Choices]

4.12 Biopsies liquides

Cancer Took His Wife. Now He's CEO Of One Of The Most Audacious Cancer Startups In Years [Forbes]


Former Google executive to lead cancer diagnostics firm [Reuters]

5. Traitements

AZD2811 ACCURINS® Data Published in Science Translational Medicine Highlight One of the First Applications of Nanomedicine to Molecularly Targeted Cancer Therapies [BIND]

The Chloroquine Story in Cancer Continues [In the Pipeline]

Nano-caging gives a failed cancer drug new life [STAT]

NICE publishes new guidance to improve care for people with incurable blood cancer [NICE]

Academic Research in Breast Cancer [ESMO]

5.2 Pharma

Ferring pits prostate cancer drug against AbbVie's Lupron in PhIIIb CV outcomes study [FierceBiotech]

5.2.3 Pharma - économie

'I would not want to be a cancer patient in England' says Pfizer boss [The Telegraph]

Novartis says CDF proposals place “unreasonable” risk on pharma [Pharmafile]

5.3 Traitements - FDA, EMA,...

EU agency accepts Sandoz application for pegfilgrastim biosimilar [Reuters]

6.1 Observation

Attention problems persist in childhood leukemia survivors treated with chemotherapy alone [St. Jude Children Research's Hospital]

Cancer Surgery At Low-Volume Hospitals In California [Health Affairs]

6.10 Politiques

President’s Budget a Stunning Jumpstart to “Moonshot” Initiative, Sustained Research Funding Still Needed [ASCO]

Biden picks adviser — and survivor — to oversee 'moonshot' [STAT]

6.3 Associations

Groups push pharma agenda under the guise of patient advocacy [HealthNewsReview]

6.6 Publications

85% of Health Research is Wasted: How to do great research, get it published, and improve health outcomes [LSE]

6.8 Communication

Press releases stink. Here’s why that matters [STAT]